Novartis Pharma AG, Basel, Switzerland.
Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):622-30. doi: 10.1002/pds.2247. Epub 2011 Oct 12.
The detection of safety signals with medicines is an essential activity to protect public health. Despite widespread acceptance, it is unclear whether recently applied statistical algorithms provide enhanced performance characteristics when compared with traditional systems. Novartis has adopted a novel system for automated signal detection on the basis of disproportionality methods within a safety data mining application (Empirica™ Signal System [ESS]). ESS uses two algorithms for routine analyses: empirical Bayes Multi-item Gamma Poisson Shrinker and logistic regression (LR).
A model was developed comprising 14 medicines, categorized as "new" or "established." A standard was prepared on the basis of safety findings selected from traditional sources. ESS results were compared with the standard to calculate the positive predictive value (PPV), specificity, and sensitivity. PPVs of the lower one-sided 5% and 0.05% confidence limits of the Bayes geometric mean (EB05) and of the LR odds ratio (LR0005) almost coincided for all the drug-event combinations studied.
There was no obvious difference comparing the PPV of the leading Medical Dictionary for Regulatory Activities (MedDRA) terms to the PPV for all terms. The PPV of narrow MedDRA query searches was higher than that for broad searches. The widely used threshold value of EB05 = 2.0 or LR0005 = 2.0 together with more than three spontaneous reports of the drug-event combination produced balanced results for PPV, sensitivity, and specificity.
Consequently, performance characteristics were best for leading terms with narrow MedDRA query searches irrespective of applying Multi-item Gamma Poisson Shrinker or LR at a threshold value of 2.0. This research formed the basis for the configuration of ESS for signal detection at Novartis.
药品安全性信号检测对于保护公众健康至关重要。尽管已被广泛接受,但目前尚不清楚与传统系统相比,最近应用的统计算法是否具有更好的性能特征。诺华公司在安全数据挖掘应用程序(Empirica™信号系统[ESS])中采用了一种基于比例失衡方法的新型自动化信号检测系统。ESS 常规分析使用两种算法:经验贝叶斯多项目伽马泊松收缩和逻辑回归(LR)。
建立了一个包含 14 种药物的模型,分为“新”药和“老”药。基于从传统来源选择的安全性发现,制定了一个标准。将 ESS 结果与标准进行比较,以计算阳性预测值(PPV)、特异性和敏感性。对于研究的所有药物-事件组合,下侧 5%和 0.05%置信限的贝叶斯几何均值(EB05)和 LR 比值比(LR0005)的 PPV 几乎一致。
与所有术语的 PPV 相比,主要医疗保健药物监管活动术语(MedDRA)的 PPV 没有明显差异。窄 MedDRA 查询搜索的 PPV 高于宽搜索。广泛使用的 EB05=2.0 或 LR0005=2.0 阈值以及药物-事件组合的超过三个自发报告产生了平衡的 PPV、敏感性和特异性结果。
因此,窄 MedDRA 查询搜索的主导术语的性能特征最好,无论应用多项目伽马泊松收缩还是 LR,阈值为 2.0。这项研究为诺华公司的 ESS 信号检测配置奠定了基础。